CSL · 9 hours ago
Senior Manager, Global Feasibility Lead
CSL is a biotech company focused on innovation to deliver impactful therapies for patients. The Senior Manager, Global Feasibility Lead will be responsible for supporting global feasibility assessments across clinical development programs, ensuring that activities are data-driven and aligned with operational strategies.
Responsibilities
Lead the design and implementation of global feasibility strategies to support protocol optimization and country/site selection
Partner with clinical operations, therapeutic area leads, and external vendors to gather input and align feasibility outputs with study needs
Analyze historical data, epidemiology, and site performance metrics to generate enrollment forecasts and identify potential risks
Oversee the development and deployment of feasibility tools and templates to ensure consistency and quality across programs
Facilitate early engagement with investigators and sites to validate feasibility assumptions and support study startup planning
Act as the primary point of contact both internally and externally (e.g., vendors) as applicable for anything study related
Maintain up to date knowledge of the therapeutic area/product candidate(s), clinical practice, competitors, and regulatory considerations
Support audits/inspections and resolutions of findings
Support in the development of new SOPs, guidelines etc and/or participate in working groups about new processes
Qualification
Required
Bachelor's degree or equivalent in life science, nursing, pharmacy, medical laboratory technology, or other health/medical related area preferred
7+ years' relevant clinical research (or related) experience within the pharmaceutical industry
A solid understanding of the drug development process, and specifically, each step within the clinical trial process
Experience in running feasibility activities for large and/or complex global clinical trials
Robust budget forecasting and management experience
Thorough knowledge of ICH guidelines/GCP and its applicability to all stages of the clinical development process
Company
CSL
CSL develops innovative biotherapies and influenza vaccines that save lives, and help people with life-threatening medical conditions.
Funding
Current Stage
Public CompanyTotal Funding
$111M2013-12-20Acquired
2004-02-06Post Ipo Equity· $111M
1994-06-03IPO
Recent News
Pharma Letter
2026-01-03
2025-10-29
Company data provided by crunchbase